Optical targeting typically involves the use of gold nanoparticles or quantum dots that exhibit unique optical properties. These nanoparticles are conjugated with therapeutic agents and directed to the target site. When exposed to light of a certain wavelength, the nanoparticles either release the drug or produce a photothermal effect, leading to the destruction of target cells.
